<PAGE>

                   U.S. SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549



                                 FORM 10-QSB



           QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                      SECURITIES EXCHANGE ACT OF 1934

               For the quarterly period ended:  June 30, 2000


                        Commission file number: 0-28154



                            SMLX TECHNOLOGIES, INC.
      -----------------------------------------------------------------
      (Exact name of small business issuer as specified in its Charter)



           Colorado                                       84-1337509
-------------------------------                        ------------------
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization)                         Identification No.)



                 376 Ansin Boulevard, Hallandale, Florida 33009
          ------------------------------------------------------------
          (Address of principal executive offices, including zip code)


                              (954) 455-0110
                        ---------------------------
                        (Issuer's telephone number)


Indicate by check mark whether the Issuer (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Exchange Act during the past 12
months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the
past 90 days.

                             Yes [ X ]   No [   ]


There were 12,104,648 shares of the Registrant's Common Stock outstanding as
of August 11, 2000.

<PAGE>
                                    INDEX


Part I: Financial Information                                     Page No.

Item 1. Financial Statements:

     Unaudited Consolidated Balance Sheets - as of
     June 30, 2000 and December 31, 1999 ........................    3-4

     Unaudited Consolidated Statements of Operations, Six and
     Three Months Ended June 30, 2000 and June 30, 1999 .........     5

     Unaudited Consolidated Statement of Cash Flows, Six
     Months Ended June 30, 2000 and June 30, 1999 ................    6

     Notes to Consolidated Financial Statements...................   7-8

Item 2. Management's Discussion and Analysis of
        Financial Condition and Results of Operations ............   10

Part II: Other Information........................................   11

     Item 1.  Legal Proceedings...................................   11

     Item 2.  Change in Securities................................   11

     Item 3.  Defaults Upon Senior Securities.....................   11

     Item 4.  Submission of Matters to a Vote
              of Security Holders.................................   11

     Item 5.  Other Information...................................   11

     Item 6.  Exhibits and Reports on Form 8-K....................   11

Signatures .......................................................   11





















                                       2
<PAGE>

                   SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                         CONSOLIDATED BALANCE SHEETS
                               (UNAUDITED)

                                                  6/30/00       12/31/99
                                                ----------     ----------
              ASSETS

CURRENT ASSETS
  Cash                                          $  159,319     $  215,026
  Accounts Receivable (Net of allowance for
   uncollectible accounts of $2,786 for
   6/30/00 and 12/31/99                                716          6,071
  Inventory                                        228,614        129,398
  Prepaid Expenses                                  25,972         23,299
                                                ----------     ----------
     Total Current Assets                          414,621        373,794
                                                ----------     ----------

Property, Plant and Equipment, at cost
 (Net of accumulated depreciation and
  amortization of $242,642 and $197,336
  on 06/30/00 and 12/31/99, respectively)          387,962        418,547

OTHER ASSETS
  Deposits                                           8,092          8,192
  Other Intangible Assets (net of accumulated
   amortization of $1,425 and $1,076 on 6/30/00
   and 12/31/99, respectively)                         465            814
  Patents and Trademarks
   (Net of accumulated amortization of $1,386
    and $969 on 6/30/00 and 12/31/99,
    respectively)                                  120,385         88,309
  Investment in Common Stock                       200,000        200,000
                                                ----------     ----------

Total Assets                                    $1,131,525     $1,089,656
                                                ==========     ==========


















The accompanying notes are an integral part of these consolidated financial
statements.

                                        3
<PAGE>


                   SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                         CONSOLIDATED BALANCE SHEETS
                               (UNAUDITED)

                                                  6/30/00       12/31/99
                                                ----------     ----------
          LIABILITIES

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
  Accounts Payable and Accrued Liabilities      $  181,893     $  190,164
  Current Portion of Notes Payable                  16,913         16,913
  Customer Deposits                                 31,870        180,841
                                                ----------     ----------
     Total Current Liabilities                     230,676        387,918
                                                ----------     ----------

LONG-TERM DEBT
  Notes Payables, Net of Current Portion           314,446        310,636
                                                ----------     ----------

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
  Common Stock (Par Value $.0001, Authorized
   100,000,000 Shares, Issued and Outstanding
   12,104,648 Shares on 6/30/00 and 11,544,648
   on 12/31/99)                                      1,200          1,154
  Preferred Stock (Par Value $.0001, Authorized
   10,000,000 Shares, No Shares Issued and
   Outstanding)                                          -              -
  Additional Paid-In Capital                     2,450,477      2,450,516
  Deficit Accumulated                           (1,865,274)    (2,060,568)
                                                ----------     ----------
     Total Stockholders' Equity                    586,403        391,102
                                                ----------     ----------
     Total Liabilities and Stockholders'
      Equity                                    $1,131,525     $1,089,656
                                                ==========     ==========















The accompanying notes are an integral part of these consolidated financial
statements.

                                        4
<PAGE>


                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENT OF OPERATIONS
                                  (UNAUDITED)
<TABLE>
<CAPTION>
                                       SIX MONTHS ENDED        THREE MONTHS ENDED
                                     6/30/00      6/30/99     6/30/00      6/30/99
                                   ----------   ----------   ----------   ----------
<S>                                <C>          <C>          <C>          <C>

REVENUES - NET                     $  962,595   $  406,372   $  390,106   $  356,221

COST OF GOODS SOLD                    143,467       25,506       70,122        3,502
                                   ----------   ----------   ----------   ----------

GROSS PROFIT                          819,128      380,866      319,984      352,719

OPERATING EXPENSES
 SELLING, GENERAL AND ADMINIS-
  TRATIVE EXPENSES                    561,062      514,328      352,069      303,838
 DEPRECIATION AND AMORTIZATION
  EXPENSE                              47,350       29,964       23,972       29,964
                                   ----------   ----------   ----------   ----------

    TOTAL OPERATING EXPENSES          608,412      544,292      376,041      333,802

OPERATING PROFIT (LOSS)               210,716     (163,426)     (56,057)      18,917

INTEREST EXPENSE                      (15,422)     (19,953)      (7,778)      (9,076)
                                   ----------   ----------   ----------   ----------

NET INCOME (LOSS)                     195,294     (183,379)     (63,835)       9,841

NET INCOME (LOSS) PER SHARE             0.016       (0.016)      (0.005)       0.001

WEIGHTED AVERAGE NUMBER OF
 SHARES OUTSTANDING                12,004,648   11,540,000   12,004,648   11,540,000

</TABLE>



















The accompanying notes are an integral part of these consolidated financial
statements.


                                       5
<PAGE>

                    SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (UNAUDITED)

                                                    SIX MONTHS ENDED
                                                 6/30/00        6/30/99
                                                ----------     ----------

CASH FLOWS FROM OPERATING ACTIVITIES:
  Net Profit (Loss)                             $  195,294  $   (183,379)

  Adjustment to Reconcile Net (Loss) to
    Net Cash Provided By (Used in)
    Operating Activities:

      Depreciation and Amortization                 47,350         29,964

      Changes in Operating Assets and
      Liabilities:

       Accounts Receivable                            (716)        (3,176)
       Inventory                                   (99,216)        (2,108)
       Deposits                                       (100)      (123,611)
       Accounts Payable and Accrued Liabilities     (8,271)             -
       Customer Deposits                          (148,971)        56,720
       Prepaid Expenses and Organization
        Expenses                                     2,673          2,367
                                                ----------     ----------
  Net Cash (Used In) Provided By Operating
   Activities                                      (11,957)      (223,223)
                                                ----------     ----------

CASH FLOWS FROM INVESTING ACTIVITIES:
  Acquisition of Fixed Assets                      (20,724)        (3,095)
  Patent Costs                                     (32,076)        (8,397)
                                                ----------     ----------
  Net Cash Provided by (Used In) Investing
   Activities                                      (52,800)       (11,492)
                                                ----------     ----------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from Private Placement                        -        636,003
  Proceeds from Notes Payable                        9,050       (133,217)
                                                ----------     ----------
Net Cash Provided By (Used In) Financing
  Activities                                         9,050        502,786
                                                ----------     ----------

Net Increase (Decrease) in Cash                    (55,707)       268,071

Cash - Beginning of Period                         215,026         47,594
                                                ----------     ----------

Cash - End of Period                            $  159,319     $  315,665
                                                ==========     ==========

The accompanying notes are an integral part of these consolidated financial
statements.

                                      6
<PAGE>

                     SMLX TECHNOLOGIES,INC. AND SUBISDIARY
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                June 30, 2000
                                 (UNAUDITED)

NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements of SMLX
Technologies, Inc. (the "Company") and its wholly-owned subsidiaries, Simplex
Medical Systems, Inc.(a Florida corporation) and Analyte Diagnostics, Inc.,
have been prepared in accordance with the instructions and requirements of
Form 10-QSB and, therefore, do not include all information and footnotes
necessary for a fair presentation of financial position, results of
operations, and cash flows in conformity with generally accepted accounting
principles.  In the opinion of management, such financial statements reflect
all adjustments (consisting only of normal recurring accruals) necessary for a
fair presentation of the results of operations and financial position for the
interim periods presented.  Operating results for the interim periods are not
necessarily indicative of the results that may be expected for the full year.
These financial statements should be read in conjunction with the Company's
annual report of Form 10-KSB.

These financial statements give effect to the March 5, 1997 reverse
acquisition whereby Music Tones Ltd. (name subsequently changed to Simplex
Medical Systems, Inc.) acquired all of the outstanding common stock of Simplex
Medical Systems, Inc. as if the transaction occurred on September 15, 1995.

NOTE 2 - BASIS OF PRESENTATION AND CONTINUED EXISTENCE

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern.  Since inception, the Company has
experienced losses aggregating $1,865,274 and has been dependent upon loans
from stockholders and other third parties in order to satisfy operations to
date.  Management believes that funds generated from operations will provide
the Company with sufficient cash flow resources to fund the operations of the
Company.  The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets
or the amounts and classification of liabilities that may result from the
possible inability of the Company to continue as a going concern.

NOTE 3 - INVENTORY

Inventory consists of $228,614 of finished goods as of June 30, 2000.

NOTE 4 - PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consists of the following at June 30, 2000:

       Leasehold Improvements                           $ 188,806
       Office Furniture and Equipment                      50,502
       Lab Equipment                                      391,296
                                                        ---------
       Total Equipment                                    630,604
           Less:  Accumulated Depreciation                242,642
                                                        ---------
       Total Property, Plant and Equipment              $ 387,962
                                                        =========

                                      7
<PAGE>

NOTE 5 - NOTES PAYABLE

       Interest Expense for the period ended
       June 30, 2000, amounted to:                $  15,422

       Interest Expense for the period ended
       June 30 , 1999, amounted to:               $  19,953

NOTE 6 - INCOME TAXES

To date the Company has incurred tax operating losses and therefore has
generated no income tax liabilities.  As of June 30, 2000, the Company has
generated net operating loss carry forwards totaling $(1,865,274) which are
available to offset future taxable income, if any, through the year 2011. As
utilization of such an operating loss for tax purposes is not assured, the
deferred tax asset has been fully reserved through the recording of 100%
valuation allowance.

The components of the net deferred tax asset are as follows at June 30, 2000:

      Deferred Tax Assets:
         Net Operating Loss Carry forward             634,193

      Valuation Allowance                            (634,193)

NOTE 7 - CONCENTRATIONS

During the six months ended June 30, 2000, revenue of approximately $640,000
was earned from a single customer, Vector Medical Technologies, Inc.  This
represents approximately 66% of the Company's year to date revenue.

NOTE 8 - CHANGES IN SECURITIES

During the quarter ended March 31, 2000, the Company issued 460,000 shares of
its Common Stock which were not registered under the Securities Exchange Act
of 1933, as amended.  The shares were issued pursuant to a writ of mandamus
issued by the Circuit Court of Miami-Dade County in connection with a lawsuit
filed against the Company by John Faro.  The shares are being held in escrow
pending a resolution of various claims against Mr. Faro.

NOTE 9 - SUBSEQUENT EVENTS

In July 2000, James Whidden was elected President of the Company by a vote of
the Board of Directors.  James Whidden is an officer and a member of the Board
of Directors of Vector Medical Technologies, Inc. as well as the President of
Whidden & Associates, Inc.

As of July 1, 2000, an agreement for the consulting and business development
services of James Whidden was entered into with Whidden & Associates, Inc., a
consulting company with experience in businesses similar to the Company's.
For two years, annual consulting fees of $80,000 will be paid in installments
of approximately $6,667 per month.  The Company has the right to terminate
this agreement at any time, subject to certain fees, if termination is during
the first twenty-four months of this agreement.



                                      8
<PAGE>

In connection with this agreement, the Company has granted options to purchase
875,000 Common Shares of the Company stock at $0.46 per share to an entity
controlled by James Whidden, for five years beginning July 1, 2000.  Options
to purchase 200,000 shares of the 875,000 became vested upon execution of the
agreement.  The options to purchase the additional 675,000 shares become
vested upon the Company's stock reaching prices between $2.00 per share and
$6.00 per share, subject to minimum daily stock trading volume.  In addition,
the Company granted options to purchase 250,000 common shares for $3.00 per
share to the entity controlled by James Whidden.  These options expire on July
1, 2002.















































                                      9
<PAGE>

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND
        RESULTS OF OPERATIONS.

     This Report contains forward-looking statements that involve a number of
risks and uncertainties.  While these statements represent the Company's
current judgement in the future direction of the business, such risks and
uncertainties could cause actual results to differ materially from any future
performance suggested herein.  Certain factors that could cause results to
differ materially from those projected in the forward-looking statements
include timing of orders and shipments, market acceptance of products, ability
to increase level of production, impact of government requisitions,
availability of capital to finance growth and general economic conditions.

     The following should be read in conjunction with the attached Financial
Statements and Notes thereto of the Company.

RESULTS OF OPERATIONS

     THREE MONTHS ENDED JUNE 30, 2000 VERSUS THREE MONTHS ENDED JUNE 30, 1999

     During the three months ended June 30, 2000, the Company had $390,106 in
revenue compared to $356,221 in revenue during the corresponding prior year
period.  The increase was the result of additional revenues from Vector
Medical of approximately $33,000 during 2000.

     Expenses for the three months ended June 30, 2000, were approximately the
same for the corresponding prior year period.

     SIX MONTHS ENDED JUNE 30, 2000 VERSUS SIX MONTHS ENDED JUNE 30, 1999

     During the six months ended June 30, 2000, the Company had $962,595 in
revenue compared to $406,372 in revenue during the corresponding prior year
period.  The increase in revenue was the result of sales of airbrators of
$284,000 (all of which occurred during the quarter ended March 31, 2000) and
increased revenues from Vector Medical of approximately $158,372 during 2000.

     Expenses for the six months ended June 30, 2000, were approximately the
same for the corresponding prior year period.

LIQUIDITY AND CAPITAL RESOURCES

     As of June 30, 2000, the Company had working capital of approximately
$183,945 compared to approximately $(14,241) at December 31, 1999.  The
increase is due to the net income for the six months.

     As of June 30, 2000, the Company had no material commitments for capital
expenditures.











                                      10
<PAGE>

                        PART II:  OTHER INFORMATION

Item 1.  Legal Proceedings:

     None

Item 2.  Changes in Securities:

     None.

Item 3.  Defaults Upon Senior Securities:

     None

Item 4.  Submission of Matters to a Vote of Security Holders:

     None

Item 5.  Other Information:

     In July 2000, James Whidden was elected President of the Company by a
vote of the Board of Directors.  James Whidden is an officer and a member of
the Board of Directors of Vector Medical Technologies, Inc. as well as the
President of Whidden & Associates, Inc.

Item 6.  Exhibits and Reports on Form 8-K:

    (a)  Exhibit 27   Financial Data Schedule       Filed herewith
                                                    electronically

    (b)  Reports on Form 8-K:   None


                                  SIGNATURES

     Pursuant to the requirements of the Securities and Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                      SMLX TECHNOLOGIES, INC.



Date:  August 17, 2000                By:/s/ James Whidden
                                         James Whidden, President



Date:  Augsut 17, 2000                By:/s/ Joel Marcus
                                         Joel Marcus, Chief Financial
                                         Officer







                                    11
<PAGE>

                               EXHIBIT INDEX
EXHIBIT                                               METHOD OF FILING
-------                                        ------------------------------
  27.     Financial Data Schedule               Filed herewith electronically